National Cancer Institute; Notice of Closed Meetings, 20370 [2010-8984]
Download as PDF
<![CDATA[
20370
Federal Register / Vol. 75, No. 74 / Monday, April 19, 2010 / Notices
wwoods2 on DSK1DXX6B1PROD with NOTICES_PART 1
data collection instrument, rounded to
the nearest dollar.
Request for Comments: Your written
comments and/or suggestions are
invited on one or more of the following
points: (a) Whether the information
collection activity is necessary to carry
out an agency function; (b) whether the
agency processes the information
collected in a useful and timely fashion;
(c) the accuracy of public burden
estimate (the estimated amount of time
needed for individual respondents to
provide the requested information); (d)
whether the methodology and
assumptions used to determine the
estimates are logical; (e) ways to
enhance the quality, utility, and clarity
of the information being collected; and
(f) ways to minimize the public burden
through the use of automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology.
Direct Comments to OMB: Send your
written comments and suggestions
regarding the proposed information
collection contained in this notice,
especially regarding the estimated
public burden and associated response
time to: Office of Management and
Budget, Office of Regulatory Affairs,
Attention: Desk Officer for IHS, New
Executive Office Building, Room 10235,
Washington, DC 20503.
Send Comments and Requests for
Further Information: To request more
information on the proposed collection
or to obtain a copy of the data collection
instrument(s) and/or instruction(s)
contact: Mr. Hershel Gorham, IHS
Reports Clearance Officer, 801
Thompson Avenue, TMP, Suite 450,
Rockville, MD 20852, call non-toll free
(301) 443–5932; send via facsimile to
(301) 443–9879; or send your e-mail
requests, comments, and return address
to: hershel.gorham@ihs.gov.
Comment Due Date: Comments
regarding this information collection are
best assured of having full effect if
received within 30 days of the date of
this publication.
Dated: April 8, 2010.
Yvette Roubideaux,
Deputy Director, Indian Health Service.
[FR Doc. 2010–8842 Filed 4–16–10; 8:45 am]
BILLING CODE P
VerDate Nov<24>2008
15:04 Apr 16, 2010
Jkt 220001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Assay
Systems for Drug Efficacy in Cancer Stem
Cells.
Date: April 28, 2010.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, 6116
Executive Boulevard, Room 6006, Rockville,
MD 20852. (Telephone Conference Call)
Contact Person: Kirt Vener, PhD, Branch
Chief, Special Review and Logistics Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 6116 Executive Blvd.,
Room 8061, Bethesda, MD 20892–8329, 301–
496–7174, venerk@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Breast
Cancer Biology.
Date: May 20, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Zhiqiang Zou, MD, PhD,
Scientific Review Officer, National Cancer
Institute, National Institutes of Health, 6116
Executive Blvd., Room 8050A, MSC 8329,
Bethesda, MD 20852, zouzhiq@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Molecular
Oncology—Basic, Translational and Clinical
Studies.
Date: May 25–26, 2010
Time: 7:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: David G. Ransom, PhD,
Scientific Review Officer, Research Programs
Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
6116 Executive Blvd., Rm. 8133, Bethesda,
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
MD 20892–8328, 301–451–4757,
david.ransom@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: April 10, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2010–8984 Filed 4–16–10; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; NINDS Conference Grant
Review Panel.
Date: April 19, 2010.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852, (Virtual
Meeting).
Contact Person: Alan L. Willard, PhD,
Chief, Scientific Review Branch, NINDS/
NIH/DHHS, 6001 Executive Blvd., Suite
3208, MSC 9529, Bethesda, MD 20892–9529,
301–496–5390, willarda@ninds.nih.gov.
This notice is being published less than 15
days prior to the meeting due to timing
limitations imposed by the review funding
cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
E:\FR\FM\19APN1.SGM
19APN1
]]>Agencies
[Federal Register Volume 75, Number 74 (Monday, April 19, 2010)]
[Notices]
[Page 20370]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-8984]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Assay Systems for Drug Efficacy in Cancer Stem Cells.
Date: April 28, 2010.
Time: 1 p.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 6006, Rockville, MD 20852. (Telephone Conference Call)
Contact Person: Kirt Vener, PhD, Branch Chief, Special Review
and Logistics Branch, Division of Extramural Activities, National
Cancer Institute, NIH, 6116 Executive Blvd., Room 8061, Bethesda, MD
20892-8329, 301-496-7174, venerk@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Breast Cancer Biology.
Date: May 20, 2010.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Zhiqiang Zou, MD, PhD, Scientific Review
Officer, National Cancer Institute, National Institutes of Health,
6116 Executive Blvd., Room 8050A, MSC 8329, Bethesda, MD 20852,
zouzhiq@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Molecular Oncology--Basic, Translational and Clinical
Studies.
Date: May 25-26, 2010
Time: 7:30 a.m. to 4 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: David G. Ransom, PhD, Scientific Review Officer,
Research Programs Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 6116 Executive Blvd., Rm. 8133,
Bethesda, MD 20892-8328, 301-451-4757, david.ransom@nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: April 10, 2010.
Jennifer Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2010-8984 Filed 4-16-10; 8:45 am]
BILLING CODE 4140-01-P
